Psychiatry 22 , 120126 (2016)
BPC-157 may be one of the most talked-about peptides in the recovery and biohacking world, but the legal landscape around it is anything but straightforward
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
By using liposome encapsulation, Vitamin C is protected from degradation, allowing significantly higher plasma concentrations and longer retention times
$377 A soothing IV designed to rehydrate, reduce fever, and support recovery from viral illness